Determines anticoagulation need in hospitalized patients by risk of VTE
| Risk Factor | Points |
|---|---|
| Active cancer (Active or treated with chemotherapy and or XRT (X-ray radiation therapy) within the last six months) | 3 |
| Previous VTE (with the exclusion of superficial vein thrombosis) | 3 |
| Reduced mobility of at least 3 days (Anticipated bed rest with bathroom privileges (either because of patient’s limitations or on physician’s order) for at least 3 days.) |
3 |
| Already known thrombophilic condition / Preexisting hypercoagulable state (Carriage of defects of antithrombin, protein C or S, factor V Leiden, G20210A prothrombin mutation, antiphospholipid syndrome.) |
3 |
| Recent (≤1 mo) trauma and/or surgery | 2 |
| Elderly age (≥70 y) | 1 |
| Heart and/or respiratory failure | 1 |
| Acute myocardial infarction or ischemic stroke | 1 |
| Acute infection and/or rheumatologic disorder | 1 |
| Obesity (BMI ≥ 30) | 1 |
| Ongoing hormonal treatment | 1 |
Total score: _____________
Padua score interpretation
0 to 3 points: Lower risk; 0.3 percent risk of symptomatic VTE*
4 to 20 points: Higher risk; 11 percent risk of symptomatic VTE*
————
* 90-day risk of symptomatic VTE in patients who did not receive anticoagulation during hospitalization.
Padua score on mdcalc.com.
Reference
Chest. 2012 Feb;141(2 Suppl). https://www.ncbi.nlm.nih.gov/pubmed/22315261